Grant Guidelines and Applications
Funded Investigator Ruslan Medzhitov is interviewed at the Scientific Advisory Workshop, 2018
The Scleroderma Research Foundation (SRF) funds research aimed at understanding the pathogenesis of scleroderma and promoting the design, development, and pilot-testing of hypothesis–driven, innovative, therapeutic approaches. The SRF welcomes applications from scientists who have not previously worked on scleroderma, as well as those with substantial ongoing scleroderma–focused effort.
Criteria that will be used to make funding decisions include merit of the application, availability of funds, and programmatic priorities.
Intended for Established Investigators and New Faculty members, the SRF has several funding mechanisms tailored to projects of varying scope that are aimed at understanding the Molecular Pathogenesis and New Interventions in Scleroderma Research. With few exceptions, funding support from the SRF may not be used for administrative overhead, indirect expenses, or other institutional charges.
The SRF is dedicated to bringing talented early-career scientists to the field of scleroderma research. Two-year postdoctoral fellowships in scleroderma research may be granted to candidates who have received their MD degree or PhD degree from a U.S. medical or graduate school or equivalent educational institution. In considering candidates, emphasis will be on the quality of the research proposal and a demonstrated commitment to scleroderma research. The applications must be accompanied by a letter from the sponsoring lead investigator underscoring the commitment to scleroderma research. The deadline for receipt of new applications for an SRF postdoctoral fellowship is January 10, 2021.
SAB member Antony Rosen at the Scientific Advisory Workshop, 2018
For other questions, please contact email@example.com.